Antimicrobial susceptibilities of group B streptococci isolated between 1992 and 1996 from patients with bacteremia or meningitis
- PMID: 9624508
- PMCID: PMC105636
- DOI: 10.1128/AAC.42.6.1517
Antimicrobial susceptibilities of group B streptococci isolated between 1992 and 1996 from patients with bacteremia or meningitis
Abstract
In vitro testing of 229 group B streptococcal isolates from a variety of patients with invasive infections indicated uniform penicillin G susceptibility. However, 17 (7.4%) isolates were resistant to erythromycin and 8 (3.4%) were resistant to clindamycin. These results support the continued use of penicillin G as the drug of choice for the treatment and prevention of group B streptococcal disease.
References
- 
    - American Academy of Pediatrics, Committee on Infectious Diseases, and Committee on Fetus and Newborn. Guidelines for prevention of group B streptococcal (GBS) infection by chemoprophylaxis. Pediatrics. 1992;90:775–778. - PubMed
 
- 
    - American Academy of Pediatrics, Committee on Infectious Diseases, and Committee on Fetus and Newborn. Revised guidelines for prevention of early-onset group B streptococcal (GBS) infection. Pediatrics. 1997;99:489–496. - PubMed
 
- 
    - Baker C J, Barrett F F. Group B streptococcal infections in infants: the importance of serotypes. JAMA. 1974;230:1158–1160. - PubMed
 
- 
    - Baker C J, Edwards M S. Group B streptococcal infections. In: Remington J S, Klein J O, editors. Infectious diseases of the fetus and newborn infant. 4th ed. Philadelphia, Pa: W. B. Saunders Co.; 1995. pp. 980–1054.
 
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
- Full Text Sources
- Other Literature Sources
- Medical
 
        